Building Wireless Connectivity for Health Care


By Cindy Atoji

November 4, 2008 | BOSTON—Over the next three years, wireless mobile networks will evolve from today’s technology to next-generation capabilities, with open access allowing the use of any device or application on national bandwidths. But adoption will be slow until a standardized infrastructure is created, instead of every mobile company acting as a little fiefdom.

These were just some of the assessments made by telecommunications executives at a symposium entitled "Wireless and Mobile Services for Connected Health: What's Happening Now?" held in Boston last week, sponsored by the Center for Connected Health. And unless a viable business case is made for wireless—and until disparate industry groups learn to work together—there will be a “gap between what we are technically capable of doing and what we can actually do,” says Robert Schwarzberg, president and CEO of Sensei, a developer of mobile and web-based wellness solutions, including a cell-phone-based application for weight management. “The use of wireless or mobile is new to health, and like anything else, getting people to adopt ends up being the responsibility of us who are trying to find a way to engage them.”

A key platform for wireless health care is the cell phone, of course, said Schwarzberg and Verizon Wireless exec John Maschenic; with the increasing number of inexpensive cell phones and a variety of medical sensor devices, the cell phone as a diagnostic tool is a reality. With an estimated 3.5 billion cell phone users worldwide, text messaging in particular, already a $100 billion dollar business, will begin to be integrated into both health-IT systems and cell phones to manage and monitor health issues. “We’ll also see advancements in the use of videochat and smart band-aids, biosensors that interconnect through dedicated gateway devices or smart phones,” says Don Jones, vice president of business development for Qualcomm. Qualcomm plans to partner with carriers like Sprint Nextel or Verizon to launch a wireless mobile network that would allow people to use their cell phones to manage and monitor health issues, such as diabetes or dieting.

The success of the Apple iPhone has also created a tremendous opportunity in the wireless marketplace, with over 250 applications out of 6,000 related to health and lifestyles. “Apple is not a one-size-fits all solution, but just part of the ecosystem,” says Anand Iyer, head of WellDoc. “If you have a glucose meter, for example, it has to work across heterogeneous networks and encompass multiple devices and applications to deliver a measurable, and intangible health and economic outcome.”

To grow the wireless market, says Schwarzberg of Sensei, “it is the user experience that is critical, not the hardware. We need to create a value proposition that no one can deny and a way to have a user interface and experience that makes it so worthwhile that people will want to become engaged and empowered to do patient-centric health care. The technology is ready, but are we willing to adopt it?”

 

 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.